Abstract
Prenatal care and the practice of prenatal genetic testing are about to be changed fundamentally. Due to several ground-breaking technological developments prenatal screening and diagnosis (PND) will soon be offered earlier in gestation, with less procedure-related risks and for a profoundly enlarged variety of targets. In this paper it is argued that the existing normative framework for prenatal screening and diagnosis cannot answer adequately to these new developments. In concentrating on issues of informed consent and the reproductive autonomy of the pregnant women the ethical debate misses problems related to the clinical pathway as a whole and to implicit normative attributions to clinical actions or the function of health care professionals. If, however, ethical debate would focus on the clinical context and on the ends of PND to a larger extent, it would be able to provide a more comprehensive analysis of the ethical challenges especially of the new technologies in order to be more adequately prepared for their implementation.
Similar content being viewed by others
Notes
McGraw-Hill Concise Dictionary of Modern Medicine 2002.
References
Buchanan, A., D.W. Brock, N. Daniels, and D. Wikler. 2000. From chance to choice. Genetics & Justice. Cambridge, New York: Cambridge University Press.
Chervenak, F.A., and L.B. McCullough. 2003. The fetus as a patient: An essential concept for the ethics of perinatal medicine. American Journal of Perinatology 20(8): 399–404.
Chitty, L.S., C.E. van der Schoot, S. Hahn, and N.D. Avent. 2008. SAFE—the special non-invasive advances in fetal and neonatal evaluation network: aims and achievements. Prenatal Diagnosis 28(2): 83–88.
Chiu, R.W., R. Akolekar, Y.W. Zheng, T.Y. Leung, H. Sun, K.C. Chan, et al. 2011. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: Large scale validity study. BMJ 342: c7401.
Davidson, R.G. 1972. Prenatal diagnosis of genetic disorders: Trials and tribulations. Clinical Chemistry 18(3): 179–187.
Deans, Z., and A. Newson. 2011. Should non-invasiveness change informed consent procedures for prenatal diagnosis? Health Care Analysis 19(2): 122–132.
De Jong, A., W.J. Dondorp, C.E. de Die-Smulders, S.G. Frints, and G.M. de Wert. 2010. Non-invasive prenatal testing: ethical issues explored. European Journal of Human Genetics 18(3): 272–277.
De Jong A., W.J. Dondorp, S.G. Frints, C.E. de Die-Smulders, and G.M. de Wert. 2011a. Non-invasive prenatal diagnosis for aneuploidy:toward an integral ethical assessment. Human Reproduction 26(11): 2915–2917.
De Jong, A., W.J. Dondorp, S.G. Frints, C.E. de Die-Smulders, and G.M. de Wert. 2011b. Advances in prenatal screening: The ethical dimension. Nature Reviews Genetics 12: 657–663.
Dworkin, G. 1988. The theory and practice of autonomy. Cambridge: Cambridge University Press.
Engelhardt Jr, H.T. 1996. The foundations of bioethics, 2nd ed, 189–238. New York: Oxford University Press.
European Surveillance of Congenital Anomalies (EUROCAT). 2010. Special report: prenatal screening policies in Europe. www.eurocat.ulster.ac.uk. Accessed 6 Jan 2012.
Fan, H.C., Y.J. Blumenfeld, U. Chitkara, L. Hudgins, and S.R. Quake. 2008. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A 105(24): 16266–16271.
Fan, H.C., and S.R. Quake. 2010. In principle method for noninvasive determination of the fetal genome. Nature Precedings. doi:10.1038/npre.2010.5373.1.
Federal Centre of Health Education (Bundeszentrale für gesundheitliche Aufklärung, BZgA). 2006. Experience of pregnancy and prenatal diagnosis. Representative survey of pregnant women on the subject of prenatal diagnosis. http://www.bzga.de/?uid=54fef95d6f432e81cd0178d17b77b7d4&id=medien&sid=88&idx=1496. Accessed 2 Oct 2011.
Ferguson-Smith, M.E., M.A. Ferguson-Smith, N.C. Nevine, and A. Stone. 1971. Chromosome analysis before birth and its value in genetic counselling. BMJ 4(5779): 69–74.
Fuchs, M., and D. Lanzerath (Eds). 2004. Prädiktive gentests. “Health Purposes” und Indikationsstellung als Kriterien der Anwendung.
Greely, H.T. 2011. Get ready for the flood of fetal gene screening. Nature 469(7330): 289–291.
Grosse, S.D., and M.J. Khoury. 2006. What is the clinical utility of genetic testing? Genetics in Medicine 8(7): 448–450.
Haker, H. 2008. Ethische Dimensionen in der Pränatalen Diagnostik. In Der Beratungsprozess in der Pränatalen Diagnostik, ed. D.C. Hürlimann, R. Baumann-Hölzle, and H. Müller, 43–68. Bern: Peter Lang.
Hofmann, B. 2003. Medicine as techne—A perspective from antiquity. Journal of Medicine and Philosophy 28(4): 403–425.
Lanzerath, D. 2000. Krankheit und ärztliches Handeln. München: Alber.
Lo, Y.M., K.C. Chan, H. Sun, E.Z. Chen, P. Jiang, F.M. Lun, et al. 2010. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Science Translational Medicine 2(61): 61ra91.
Lo, Y.M., N.B. Tsui, R.W. Chiu, T.K. Lau, T.N. Leung, M.M. Heung, et al. 2007. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nature Medicine 13(2): 218–223.
Manson, N.C., and O. O’Neill. 2007. Rethinking informed consent in bioethics. Cambridge: Cambridge University Press.
Newson, A.J. 2008. Ethical aspects arising from non-invasive fetal diagnosis. Seminars in Fetal and Neonatal Medicine 13(2): 103–108.
O’Neill, O. 2002. Autonomy and trust in bioethics. Cambridge, New York: Cambridge University Press.
O’Neill, O. 2003. Some limits of informed consent. Journal of Medical Ethics 29(1): 4–7.
Pippin, R.B. 1996. Medical practice and social authority. Journal of Medicine and Philosophy 21(4): 417–437.
Savulescu, J. 2001. Procreative beneficence: Why we should select the best children. Bioethics 15(5–6): 413–426.
Schmitz, D., C. Netzer, and W. Henn. 2009. An offer you can’t refuse? Ethical implications of non-invasive prenatal diagnosis. Nature Reviews Genetics 10: 515.
Wiesemann, C. 2006. Von der Verantwortung, ein Kind zu bekommen. Eine Ethik der Elternschaft. München: C.H. Beck.
Wright, C. 2009. Cell-free fetal nucleic acids for non-invasive prenatal diagnosis. Report of the UK expert working group. PHG Foundation.
Acknowledgments
The author wishes to thank two anonymous reviewers for insightful comments on an earlier version of this paper.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schmitz, D. A new era in prenatal testing: are we prepared?. Med Health Care and Philos 16, 357–364 (2013). https://doi.org/10.1007/s11019-012-9411-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11019-012-9411-y